Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Primary care physician decision making regarding referral for bariatric surgery: a national survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effect of bariatric surgery on plasma GDF15 in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Gastric bypass surgery leads to profound changes in the secretion of gut hormones with effects on metabolism, appetite, and food intake. Here, we discuss their contributions to the improvement in glucose tolerance and the weight loss that results from the operations. We find that the improved glucose tolerance is due the following events: a negative energy balance and resulting weight loss, which improve first hepatic and later peripheral insulin sensitivity, in combination with increased postprandial insulin secretion elicited particularly by exaggerated glucagon-like peptide-1 responses. The weight loss is due to loss of appetite resulting in reduced energy intake, and we find it probable that this process is driven by exaggerated secretion of appetite-regulating gut hormones including, but probably not limited to, glucagon-like peptide-1 and peptide-YY. The increased secretion is due to an accelerated exposure to and absorption of nutrients in the small intestine. This places the weight loss and the gut hormones in key positions with respect to the metabolic improvements after bypass surgery.

Original languageEnglish
JournalSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Volume14
Issue number5
Pages (from-to)708-714
ISSN1550-7289
DOIs
Publication statusPublished - 1 May 2018

ID: 54347502